Baker Brothers Advisors - FIBROGEN INC ownership

FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 111 filers reported holding FIBROGEN INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of FIBROGEN INC
ValueSharesWeighting
Q2 2023$642,827
-98.7%
238,084
-91.0%
0.00%
-98.5%
Q1 2023$49,213,585
+123.4%
2,637,384
+91.8%
0.27%
+103.0%
Q4 2022$22,030,880
+107.6%
1,375,211
+68.6%
0.13%
+91.3%
Q3 2022$10,612,000
+23.2%
815,7180.0%0.07%
+40.8%
Q2 2022$8,614,000
+23.2%
815,718
+40.2%
0.05%
+22.5%
Q1 2022$6,993,000
-14.5%
581,750
+0.3%
0.04%0.0%
Q4 2021$8,180,000580,1500.04%
Other shareholders
FIBROGEN INC shareholders Q3 2023
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 305,784$8,143,0008.63%
Vantage Consulting Group Inc 605,713$16,130,0002.81%
GREAT POINT PARTNERS LLC 500,000$13,315,0002.79%
HHLR ADVISORS, LTD. 3,955,787$105,343,0001.08%
Intercontinental Wealth Advisors, LLC 191,300$5,094,0001.01%
Ikarian Capital, LLC 250,000$6,657,0000.54%
BHK Investment Advisors, LLC 45,100$1,201,0000.49%
Ikarian Capital, LLC 193,800$5,161,0000.42%
Omega Fund Management, LLC 130,646$3,479,0000.39%
Rhenman & Partners Asset Management AB 200,000$5,326,0000.36%
View complete list of FIBROGEN INC shareholders